Back to Search
KATHIRENE WILCOXEN, M.D.
M.D.
Pediatrics Physician
NPI: 1760758742Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
01075220(IN)
Research & Publications (18)
Synthesis of 3-phenylpyrazolo[4,3-b]pyridines via a convenient synthesis of 4-amino-3-arylpyrazoles and SAR of corticotropin-releasing factor receptor type-1 antagonists.
PMID 12951127·Bioorg Med Chem Lett·2003
8-other
Synthesis and initial structure-activity relationships of a novel series of imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists.
PMID 12127532·Bioorg Med Chem Lett·2002
8-other
Recent advances of MEK inhibitors and their clinical progress.
PMID 17692026·Curr Top Med Chem·2007
6-review
Functional and mechanistic analyses of biomimetic aminoacyl transfer reactions in de novo designed coiled coil peptides via rational active site engineering.
PMID 17302417·J Am Chem Soc·2007
8-other
Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections.
PMID 15993611·Bioorg Med Chem·2005
7-preclinical
Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists.
PMID 15341493·J Med Chem·2004
7-preclinical
Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonists.
PMID 15225703·Bioorg Med Chem Lett·2004
8-other
Optimization of 3-phenylpyrazolo[1,5-a]pyrimidines as potent corticotropin-releasing factor-1 antagonists with adequate lipophilicity and water solubility.
PMID 15203140·Bioorg Med Chem Lett·2004
7-preclinical
Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists.
PMID 12951129·Bioorg Med Chem Lett·2003
7-preclinical
Synthesis of 1-methyl-3-phenylpyrazolo[4,3-b]pyridines via a methylation of 4-phthalimino-3-phenylpyrazoles and optimization toward highly potent corticotropin-releasing factor type-1 antagonists.
PMID 12951128·Bioorg Med Chem Lett·2003
8-other
Quinoline-carboxylic acids are potent inhibitors that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins.
PMID 12749901·Bioorg Med Chem Lett·2003
8-other
6,7-dihydroxyisoquinoline-3-carboxylic acids are potent inhibitors on the binding of insulin-like growth factor (IGF) to IGF-binding proteins: optimization of the 1-position benzoyl side chain.
PMID 12749900·Bioorg Med Chem Lett·2003
8-other
Design, synthesis and structure-activity relationships of novel imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists.
PMID 12127533·Bioorg Med Chem Lett·2002
7-preclinical
A novel synthesis of 2-arylpyrrolo[1,2-a]pyrimid-7-ones and their structure-activity relationships as potent GnRH receptor antagonists.
PMID 11814807·Bioorg Med Chem Lett·2002
7-preclinical
Initial structure-activity relationship studies of a novel series of pyrrolo[1,2-a]pyrimid-7-ones as GnRH receptor antagonists.
PMID 11814806·Bioorg Med Chem Lett·2002
7-preclinical
Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.
PMID 11473322·Nature·2001
7-preclinical
An improved synthesis of selectively protected L-dopa derivatives from L-tyrosine.
PMID 10789475·J Org Chem·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 721 W 13TH ST
JASPER, IN 47546 - Phone
- (812) 996-7918
Quick Facts
- NPI
- 1760758742
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile